10 results
Type of content
News Remove News filter
Categories
Human Remove Human filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
PRAC, Last updated: 09/02/2018 -
List item
Press release: Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs
PRAC, Last updated: 17/05/2019 -
List item
Press release: Withdrawal of marketing authorisations for fenspiride medicines
PRAC, Last updated: 17/05/2019 -
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
News: PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids
PRAC, Last updated: 04/09/2020 -
List item
News: EMA recommends withdrawal of marketing authorisation for amfepramone medicines
PRAC, Last updated: 10/06/2022 -
List item
News: PRAC starts review of topiramate use in pregnancy and women of childbearing potential
PRAC, Last updated: 02/09/2022 -
List item
News: Review of pholcodine medicines started
PRAC, Last updated: 02/09/2022 -
List item
News: New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
PRAC, Last updated: 30/09/2022 -
List item
News: EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
PRAC, Last updated: 28/10/2022